Scientists hunt for clues to drug resistance in head and neck cancer
NCT ID NCT07471009
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will collect tumor and blood samples from 120 people with head and neck squamous cell carcinoma. Researchers will create mouse models from the samples and analyze molecular markers to understand resistance to standard therapies. The goal is to find new treatment targets for patients whose cancer stops responding.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could identify new drug targets for patients whose head and neck cancer has become resistant to standard therapy.
- What could go wrong
- This is an observational study, not a treatment trial. It is early-stage research that may not lead directly to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL TUMORS OF THE HEAD AND NECK (HNSCC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCSS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, 40138, Italy